APO Research
Talk to an analyst

APO RESEARCH · REPORT

Swine Erysipelas Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Swine Erysipelas Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchSwine Erysipelas Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Erysipelas Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Swine Erysipelas Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Erysipelas Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Erysipelas Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Swine Erysipelas Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Swine Erysipelas Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Swine Erysipelas Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Swine Erysipelas Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Swine Erysipelas Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Swine Erysipelas Vaccine include CAHIC, Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd., Qilu Animal Health, Merck, Jiujiang Bomeilai Biological, Jilin Zhengye Biological, Hunan Zhong'an Biological Pharmaceutical Co., Ltd., Chengdu Tianbang Biology and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Swine Erysipelas Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Swine Erysipelas Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Swine Erysipelas Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Swine Erysipelas Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Swine Erysipelas Vaccine Segment by Company

CAHIC

Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.

Qilu Animal Health

Merck

Jiujiang Bomeilai Biological

Jilin Zhengye Biological

Hunan Zhong'an Biological Pharmaceutical Co., Ltd.

Chengdu Tianbang Biology

Zoetis

Boehringer Ingelheim

Swine Erysipelas Vaccine Segment by Type

Live

Inactivated

Swine Erysipelas Vaccine Segment by Application

Pharmacy

Online Sale

Others

Swine Erysipelas Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Erysipelas Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Erysipelas Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Erysipelas Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Swine Erysipelas Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Swine Erysipelas Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Swine Erysipelas Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Swine Erysipelas Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Swine Erysipelas Vaccine Industry Trends Table 2. Swine Erysipelas Vaccine Industry Drivers Table 3. Swine Erysipelas Vaccine Industry Opportunities and Challenges Table 4. Swine Erysipelas Vaccine Industry Restraints Table 5. Global Swine Erysipelas Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Swine Erysipelas Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Swine Erysipelas Vaccine Sales by Manufacturers (K Doses) & (2021-2026) Table 8. Global Swine Erysipelas Vaccine Sales Market Share by Manufacturers Table 9. Global Swine Erysipelas Vaccine Average Sales Price (US$/Dose) of Manufacturers (2021-2026) Table 10. Global Swine Erysipelas Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Swine Erysipelas Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Swine Erysipelas Vaccine Manufacturers, Product Type & Application Table 13. Global Swine Erysipelas Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Swine Erysipelas Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Live Table 17. Major Manufacturers of Inactivated Table 18. Global Swine Erysipelas Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Doses) Table 19. Global Swine Erysipelas Vaccine Sales by Type (2021-2026) & (K Doses) Table 20. Global Swine Erysipelas Vaccine Sales by Type (2027-2032) & (K Doses) Table 21. Global Swine Erysipelas Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Swine Erysipelas Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Swine Erysipelas Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Doses) Table 24. Global Swine Erysipelas Vaccine Revenue by Type (2021-2026) & (K Doses) Table 25. Global Swine Erysipelas Vaccine Revenue by Type (2027-2032) & (K Doses) Table 26. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmacy Table 29. Major Manufacturers of Online Sale Table 30. Major Manufacturers of Others Table 31. Global Swine Erysipelas Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Doses) Table 32. Global Swine Erysipelas Vaccine Sales by Application (2021-2026) & (K Doses) Table 33. Global Swine Erysipelas Vaccine Sales by Application (2027-2032) & (K Doses) Table 34. Global Swine Erysipelas Vaccine Sales Market Share by Application (2021-2026) Table 35. Global Swine Erysipelas Vaccine Sales Market Share by Application (2027-2032) Table 36. Global Swine Erysipelas Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Doses) Table 37. Global Swine Erysipelas Vaccine Revenue by Application (2021-2026) & (K Doses) Table 38. Global Swine Erysipelas Vaccine Revenue by Application (2027-2032) & (K Doses) Table 39. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2021-2026) Table 40. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2027-2032) Table 41. Global Swine Erysipelas Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Doses) Table 42. Global Swine Erysipelas Vaccine Sales by Region (2021-2026) & (K Doses) Table 43. Global Swine Erysipelas Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Swine Erysipelas Vaccine Sales Forecasted by Region (2027-2032) & (K Doses) Table 45. Global Swine Erysipelas Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 47. North America Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 48. North America Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 49. Europe Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 50. Europe Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 51. Europe Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 52. Asia Pacific Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 53. Asia Pacific Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 54. Asia Pacific Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 55. South America, Middle East and Africa Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Doses) Table 56. South America, Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2021-2026) & (K Doses) Table 57. South America, Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2027-2032) & (K Doses) Table 58. Global Swine Erysipelas Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Swine Erysipelas Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Swine Erysipelas Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2021-2026) Table 62. Global Swine Erysipelas Vaccine Revenue Market Share by Region (2027-2032) Table 63. CAHIC Company Information Table 64. CAHIC Business Overview Table 65. CAHIC Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. CAHIC Swine Erysipelas Vaccine Product Portfolio Table 67. CAHIC Recent Development Table 68. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information Table 69. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Business Overview Table 70. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Portfolio Table 72. Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Development Table 73. Qilu Animal Health Company Information Table 74. Qilu Animal Health Business Overview Table 75. Qilu Animal Health Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Qilu Animal Health Swine Erysipelas Vaccine Product Portfolio Table 77. Qilu Animal Health Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck Swine Erysipelas Vaccine Product Portfolio Table 82. Merck Recent Development Table 83. Jiujiang Bomeilai Biological Company Information Table 84. Jiujiang Bomeilai Biological Business Overview Table 85. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Portfolio Table 87. Jiujiang Bomeilai Biological Recent Development Table 88. Jilin Zhengye Biological Company Information Table 89. Jilin Zhengye Biological Business Overview Table 90. Jilin Zhengye Biological Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Jilin Zhengye Biological Swine Erysipelas Vaccine Product Portfolio Table 92. Jilin Zhengye Biological Recent Development Table 93. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information Table 94. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Business Overview Table 95. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Portfolio Table 97. Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Development Table 98. Chengdu Tianbang Biology Company Information Table 99. Chengdu Tianbang Biology Business Overview Table 100. Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Portfolio Table 102. Chengdu Tianbang Biology Recent Development Table 103. Zoetis Company Information Table 104. Zoetis Business Overview Table 105. Zoetis Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Zoetis Swine Erysipelas Vaccine Product Portfolio Table 107. Zoetis Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Swine Erysipelas Vaccine Sales (K Doses), Price (US$/Dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Swine Erysipelas Vaccine Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Swine Erysipelas Vaccine Distributors List Table 116. Swine Erysipelas Vaccine Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Swine Erysipelas Vaccine Product Image Figure 2. Global Swine Erysipelas Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Erysipelas Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Swine Erysipelas Vaccine Sales (2021-2032) & (K Doses) Figure 5. Global Swine Erysipelas Vaccine Average Price (US$/Dose) & (2021-2032) Figure 6. Global Top 5 and 10 Swine Erysipelas Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Live Image Figure 9. Inactivated Image Figure 10. Global Swine Erysipelas Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 11. Global Swine Erysipelas Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Swine Erysipelas Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Swine Erysipelas Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Doses) Figure 14. Global Swine Erysipelas Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Swine Erysipelas Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Pharmacy Image Figure 17. Online Sale Image Figure 18. Others Image Figure 19. Global Swine Erysipelas Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 20. Global Swine Erysipelas Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Swine Erysipelas Vaccine Sales Market Share by Application (2021-2032) Figure 22. Global Swine Erysipelas Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Doses) Figure 23. Global Swine Erysipelas Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Swine Erysipelas Vaccine Revenue Market Share by Application (2021-2032) Figure 25. North America Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 26. North America Swine Erysipelas Vaccine Sales Market Share by Country (2021-2032) Figure 27. U.S. Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 28. Canada Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 29. Mexico Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 30. Europe Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 31. Europe Swine Erysipelas Vaccine Sales Market Share by Country (2021-2032) Figure 32. Germany Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 33. France Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 34. U.K. Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 35. Italy Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 36. Netherlands Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 37. Asia Pacific Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 38. Asia Pacific Swine Erysipelas Vaccine Sales Market Share by Country (2021-2032) Figure 39. China Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 40. Japan Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 41. South Korea Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 42. Southeast Asia Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 43. India Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 44. Australia Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 45. South America, Middle East and Africa Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 46. South America, Middle East and Africa Swine Erysipelas Vaccine Sales Market Share by Country (2021-2032) Figure 47. Brazil Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 48. South Africa Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 49. Saudi Arabia Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 50. Turkey Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 51. Argentina Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 52. UAE Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 53. Egypt Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 54. Chile Swine Erysipelas Vaccine Sales and Growth Rate (2021-2032) & (K Doses) Figure 55. Global Swine Erysipelas Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Swine Erysipelas Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Figure 58. North America Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Swine Erysipelas Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Swine Erysipelas Vaccine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Swine Erysipelas Vaccine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Live
  • Inactivated
Applications
  • Pharmacy
  • Online Sale
  • Others
Companies covered
  • CAHIC
  • Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
  • Qilu Animal Health
  • Merck
  • Jiujiang Bomeilai Biological
  • Jilin Zhengye Biological
  • Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
  • Chengdu Tianbang Biology
  • Zoetis
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Swine Erysipelas Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Swine Erysipelas Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Swine Erysipelas Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Swine Erysipelas Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Swine Erysipelas Vaccine Market Dynamics
  1. 2.1 Swine Erysipelas Vaccine Industry Trends
  2. 2.2 Swine Erysipelas Vaccine Industry Drivers
  3. 2.3 Swine Erysipelas Vaccine Industry Opportunities and Challenges
  4. 2.4 Swine Erysipelas Vaccine Industry Restraints
3 Swine Erysipelas Vaccine Market by Manufacturers
  1. 3.1 Global Swine Erysipelas Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Swine Erysipelas Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Swine Erysipelas Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Swine Erysipelas Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Swine Erysipelas Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Swine Erysipelas Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Swine Erysipelas Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Swine Erysipelas Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Swine Erysipelas Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Swine Erysipelas Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Erysipelas Vaccine Market by Type
  1. 4.1 Swine Erysipelas Vaccine Type Introduction
  2. 4.1.1 Live
  3. 4.1.2 Inactivated
  4. 4.2 Global Swine Erysipelas Vaccine Sales by Type
  5. 4.2.1 Global Swine Erysipelas Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Swine Erysipelas Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Swine Erysipelas Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Swine Erysipelas Vaccine Revenue by Type
  9. 4.3.1 Global Swine Erysipelas Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Swine Erysipelas Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Swine Erysipelas Vaccine Revenue Market Share by Type (2021-2032)
5 Swine Erysipelas Vaccine Market by Application
  1. 5.1 Swine Erysipelas Vaccine Application Introduction
  2. 5.1.1 Pharmacy
  3. 5.1.2 Online Sale
  4. 5.1.3 Others
  5. 5.2 Global Swine Erysipelas Vaccine Sales by Application
  6. 5.2.1 Global Swine Erysipelas Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Swine Erysipelas Vaccine Sales by Application (2021-2032)
  8. 5.2.3 Global Swine Erysipelas Vaccine Sales Market Share by Application (2021-2032)
  9. 5.3 Global Swine Erysipelas Vaccine Revenue by Application
  10. 5.3.1 Global Swine Erysipelas Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Swine Erysipelas Vaccine Revenue by Application (2021-2032)
  12. 5.3.3 Global Swine Erysipelas Vaccine Revenue Market Share by Application (2021-2032)
6 Global Swine Erysipelas Vaccine Sales by Region
  1. 6.1 Global Swine Erysipelas Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Swine Erysipelas Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Swine Erysipelas Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Swine Erysipelas Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Swine Erysipelas Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Swine Erysipelas Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Swine Erysipelas Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Swine Erysipelas Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Swine Erysipelas Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Swine Erysipelas Vaccine Revenue by Region
  1. 7.1 Global Swine Erysipelas Vaccine Revenue by Region
  2. 7.1.1 Global Swine Erysipelas Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Swine Erysipelas Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Swine Erysipelas Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Swine Erysipelas Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Swine Erysipelas Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Swine Erysipelas Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Swine Erysipelas Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Swine Erysipelas Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Swine Erysipelas Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Swine Erysipelas Vaccine Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd.
  8. 8.2.1 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Company Information
  9. 8.2.2 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Business Overview
  10. 8.2.3 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Swine Erysipelas Vaccine Product Portfolio
  12. 8.2.5 Zhejiang Shihua Nuo Beiwei Biotechnology Co., Ltd. Recent Developments
  13. 8.3 Qilu Animal Health
  14. 8.3.1 Qilu Animal Health Company Information
  15. 8.3.2 Qilu Animal Health Business Overview
  16. 8.3.3 Qilu Animal Health Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Animal Health Swine Erysipelas Vaccine Product Portfolio
  18. 8.3.5 Qilu Animal Health Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck Swine Erysipelas Vaccine Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Jiujiang Bomeilai Biological
  26. 8.5.1 Jiujiang Bomeilai Biological Company Information
  27. 8.5.2 Jiujiang Bomeilai Biological Business Overview
  28. 8.5.3 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiujiang Bomeilai Biological Swine Erysipelas Vaccine Product Portfolio
  30. 8.5.5 Jiujiang Bomeilai Biological Recent Developments
  31. 8.6 Jilin Zhengye Biological
  32. 8.6.1 Jilin Zhengye Biological Company Information
  33. 8.6.2 Jilin Zhengye Biological Business Overview
  34. 8.6.3 Jilin Zhengye Biological Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jilin Zhengye Biological Swine Erysipelas Vaccine Product Portfolio
  36. 8.6.5 Jilin Zhengye Biological Recent Developments
  37. 8.7 Hunan Zhong'an Biological Pharmaceutical Co., Ltd.
  38. 8.7.1 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Swine Erysipelas Vaccine Product Portfolio
  42. 8.7.5 Hunan Zhong'an Biological Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Chengdu Tianbang Biology
  44. 8.8.1 Chengdu Tianbang Biology Company Information
  45. 8.8.2 Chengdu Tianbang Biology Business Overview
  46. 8.8.3 Chengdu Tianbang Biology Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu Tianbang Biology Swine Erysipelas Vaccine Product Portfolio
  48. 8.8.5 Chengdu Tianbang Biology Recent Developments
  49. 8.9 Zoetis
  50. 8.9.1 Zoetis Company Information
  51. 8.9.2 Zoetis Business Overview
  52. 8.9.3 Zoetis Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zoetis Swine Erysipelas Vaccine Product Portfolio
  54. 8.9.5 Zoetis Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Swine Erysipelas Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Swine Erysipelas Vaccine Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Swine Erysipelas Vaccine Value Chain Analysis
  2. 9.1.1 Swine Erysipelas Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Swine Erysipelas Vaccine Production Mode & Process
  6. 9.2 Swine Erysipelas Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Swine Erysipelas Vaccine Distributors
  9. 9.2.3 Swine Erysipelas Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst